Indication
Levagen, containing 4mg of Lenvatinib in capsule form, is prescribed for treating various cancers, including thyroid, kidney, and liver cancers, under the supervision of healthcare professionals for eligible patients diagnosed with these specific cancer types.

Pharmacology
Lenvatinib, categorized as a tyrosine kinase inhibitor, operates by blocking specific proteins crucial for cancer cell growth and blood vessel formation. Through this mechanism, Lenvatinib slows down or halts tumor growth, serving as a targeted therapy for certain cancer types.

Dosage and Administration
Levagen capsules are typically administered orally as prescribed by healthcare professionals. The specific dosage and treatment schedule may vary based on individual patient factors, including the cancer type and its stage.

Interaction
Levagen has the potential to interact with various medications, including other cancer drugs and drugs metabolized by specific enzymes in the body. Patients should inform their healthcare provider about all medications, supplements, and herbal products they are using to avoid potential interactions.

Side Effects
Common side effects of Levagen may include fatigue, diarrhea, high blood pressure, decreased appetite, and nausea. More severe side effects like liver issues, bleeding, and heart problems may also occur. Patients should promptly notify their healthcare provider if they experience any severe or persistent side effects.

Precautions and Warnings
Patients undergoing Levagen treatment should undergo close monitoring for potential adverse reactions, especially liver function tests and blood pressure monitoring. Usage of Levagen during pregnancy may pose risks to the fetus, requiring contraception for both genders during treatment and a specified period afterward. Breastfeeding is not recommended while taking Levagen.

Overdose Effects
In instances of Levagen overdose, patients may experience intensified adverse effects such as gastrointestinal symptoms, high blood pressure, and liver toxicity. Overdose management typically entails supportive care and vigilant monitoring for complications. Immediate medical attention is necessary if overdose is suspected.